UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.324-325

2020

Volltextzugriff (PDF)

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

Annals of the rheumatic diseases, 2003-01, Vol.62 (1), p.81-82

2003

Volltextzugriff (PDF)

Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability

American journal of roentgenology (1976), 2002-01, Vol.178 (1), p.105-109

2002

Volltextzugriff (PDF)

POS0235 INTEGRATED SAFETY ANALYSIS UPDATE FOR FILGOTINIB (FIL) IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA) RECEIVING TREATMENT OVER A MEDIAN OF 2.2 YEARS (Y)

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.354-355

2022

Volltextzugriff (PDF)

THU0194 CHARACTERISATION OF DEPTH OF RESPONSE, INCLUDING 50% IMPROVEMENT IN ACR COMPONENTS AT WEEK 12 AND REMISSION AT WEEK 24, FOLLOWING TREATMENT WITH FILGOTINIB COMPARED WITH METHOTREXATE OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.316-317

2020

Volltextzugriff (PDF)

SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.1019-1020

2020

Volltextzugriff (PDF)

THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.320-321

2020

Volltextzugriff (PDF)

Influence of Dialysis Procedure, Membrane Surface and Membrane Material on Iopromide Elimination in Patients with Reduced Kidney Function

American journal of nephrology, 2000-07, Vol.20 (4), p.300-304

2000

Volltextzugriff (PDF)

Mise à jour de l’analyse intégrée de la tolérance du filgotinib (FIL) chez les patients atteints de polyarthrite rhumatoïde (PR) active modérée à sévère recevant un traitement (TT) sur une période médiane de 2,2 ans

Revue du rhumatisme (Ed. française : 1993), 2022-12, Vol.89, p.A270-A271

2022

Volltextzugriff (PDF)

Cyclosporine does not influence serum cholesterol in kidney transplant recipients

Transplantation proceedings, 2002-08, Vol.34 (5), p.1795-1796

2002

Volltextzugriff (PDF)

P597 Pooled safety analyses from Phase 3 studies of filgotinib in patients with rheumatoid arthritis

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S497-S498

2020

Volltextzugriff (PDF)

Analyse intégrée de 7 essais cliniques sur la tolérance du filgotinib [FIL] dans le traitement de la polyarthrite rhumatoïde [PR]

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A19-A19

2020

Volltextzugriff (PDF)

Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats

Diabetologia, 1997-09, Vol.40 (9), p.1035-1043

1997

Volltextzugriff (PDF)

Clearance of Iopromide during Haemodialysis with High- and Low-Flux Membranes

Acta radiologica (1987), 1999-03, Vol.40 (2), p.220-223

1999

Volltextzugriff (PDF)

Accurate reaction rate calculations including internal and rotational motion: A statistical multi-configurational time-dependent Hartree approach

The Journal of chemical physics, 1999-01, Vol.110 (1), p.88-96

1999

Volltextzugriff (PDF)

Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition

Transplantation proceedings, 2002-08, Vol.34 (5), p.1763-1766

2002

Volltextzugriff (PDF)

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Revue du rhumatisme (Ed. française : 1993), 2021-12, Vol.88, p.A111-A112

2021

Volltextzugriff (PDF)

Combined iterative diagonalization and statistical sampling in accurate reaction rate calculations: Rotational effects in O+HCl→OH+Cl

The Journal of chemical physics, 2000-01, Vol.112 (1), p.130-136

2000

Volltextzugriff (PDF)

Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions

Kidney international, 2003-02, Vol.63 (2), p.696-701

2003

Volltextzugriff (PDF)

MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient

Nephrology, dialysis, transplantation, 2000-01, Vol.15 (1), p.110-112

2000

Volltextzugriff (PDF)

Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome

American journal of nephrology, 1999, Vol.19 (4), p.492-494

1999

Volltextzugriff (PDF)

Iron and iron-related parameters in oncology

Trace elements and electrolytes, 2005-01, Vol.22 (4), p.142-149

2005

Volltextzugriff (PDF)

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Revue du rhumatisme (Ed. française : 1993), 2020-12, Vol.87, p.A18-A19

2020

Volltextzugriff (PDF)

Does allopurinol prevent side effects of cyclosporine-A treatment?

Transplantation proceedings, 2002-08, Vol.34 (5), p.1425-1427

2002

Volltextzugriff (PDF)

Diagnosis of iron deficiency in patients infected with human immunodeficiency virus

Haematologica (Roma), 2000-08, Vol.85 (8), p.871

2000

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS

Severe septicaemia in a patient with polychondritis and Sweet’s syndrome after initiation of treatment with infliximab

Using highly concentrated gadobutrol as an MR contrast agent in patients also requiring hemodialysis: safety and dialysability

POS0235 INTEGRATED SAFETY ANALYSIS UPDATE FOR FILGOTINIB (FIL) IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA) RECEIVING TREATMENT OVER A MEDIAN OF 2.2 YEARS (Y)

THU0194 CHARACTERISATION OF DEPTH OF RESPONSE, INCLUDING 50% IMPROVEMENT IN ACR COMPONENTS AT WEEK 12 AND REMISSION AT WEEK 24, FOLLOWING TREATMENT WITH FILGOTINIB COMPARED WITH METHOTREXATE OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

SAT0158 EFFICACY AND SAFETY OF FILGOTINIB IN METHOTREXATE-NAÏVE PATIENTS WITH RHEUMATOID ARTHRITIS: FINCH 3 52-WEEK RESULTS

THU0198 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH 1 52-WEEK RESULTS

Influence of Dialysis Procedure, Membrane Surface and Membrane Material on Iopromide Elimination in Patients with Reduced Kidney Function

Mise à jour de l’analyse intégrée de la tolérance du filgotinib (FIL) chez les patients atteints de polyarthrite rhumatoïde (PR) active modérée à sévère recevant un traitement (TT) sur une période médiane de 2,2 ans

Cyclosporine does not influence serum cholesterol in kidney transplant recipients

P597 Pooled safety analyses from Phase 3 studies of filgotinib in patients with rheumatoid arthritis

Analyse intégrée de 7 essais cliniques sur la tolérance du filgotinib [FIL] dans le traitement de la polyarthrite rhumatoïde [PR]

Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats

Clearance of Iopromide during Haemodialysis with High- and Low-Flux Membranes

Accurate reaction rate calculations including internal and rotational motion: A statistical multi-configurational time-dependent Hartree approach

Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition

ECM et TEV dans le développement clinique du filgotinib dans la polyarthrite rhumatoïde : analyse intégrée des essais cliniques de phases 2 et 3

Combined iterative diagonalization and statistical sampling in accurate reaction rate calculations: Rotational effects in O+HCl→OH+Cl

Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions

MVAC-therapy for advanced urothelial carcinoma in an anuric renal transplant recipient

Efficiency of 1-Year Treatment with Fluvastatin in Hyperlipidemic Patients with Nephrotic Syndrome

Iron and iron-related parameters in oncology

Efficacité et tolérance du filgotinib chez les patients atteints de polyarthrite rhumatoïde (PR) présentant une réponse inadéquate au méthotrexate (RI-MTX) : résultats de l’étude FINCH 1 à 52 semaines

Does allopurinol prevent side effects of cyclosporine-A treatment?

Diagnosis of iron deficiency in patients infected with human immunodeficiency virus

Suchergebnisse filtern